Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD 26.96
+0.66 (2.51%)
Oct 22, 2026, 4:08 PM HKT
HKG:3378 Revenue
Hanx Biopharmaceuticals (Wuhan) had revenue of 3.00K CNY in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 73.00K. In the year 2025, Hanx Biopharmaceuticals (Wuhan) had annual revenue of 92.00K, down -95.82%. That makes Hanx Biopharmaceuticals (Wuhan) the 47,230th largest company in the world by revenue and 2,612th in Hong Kong.
Revenue (ttm)
73.00K CNY
Revenue Growth
-95.82%
P/S Ratio
42,509.79
Revenue / Employee
1.22K CNY
Employees
60
Market Cap
3.67B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 92.00K | -2.11M | -95.82% |
| Dec 31, 2024 | 2.20M | -340.00K | -13.39% |
| Dec 31, 2023 | 2.54M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.